» Authors » Miriam Hartmann

Miriam Hartmann

Explore the profile of Miriam Hartmann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 1070
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Atujuna M, Montgomery E, Hartmann M, Ndwayana S, Browne E, Sindelo S, et al.
AIDS Behav . 2021 Oct; 26(5):1618-1632. PMID: 34716835
While pre-exposure prophylaxis (PrEP) is a key HIV prevention tool for adolescents and young adults (AYAs), its initiation and sustained use is shaped by AYAs' unique social contexts, including family....
22.
Montgomery E, Roberts S, Reddy K, Tolley E, Hartmann M, Wilson E, et al.
AIDS Behav . 2021 Sep; 26(3):752-763. PMID: 34546473
Biomedical, female-initiated HIV prevention methods can help reduce disproportionately high HIV rates among women in sub-Saharan Africa, but male partner resistance and intimate partner violence (IPV) may impact ability to...
23.
Naidoo S, Duby Z, Hartmann M, Musara P, Etima J, Woeber K, et al.
Field methods . 2021 Aug; 33(2):143-158. PMID: 34385890
Body mapping methods are used in sexual and reproductive health studies to encourage candid discussion of sex and sexuality, pleasure and pain, sickness and health, and to understand individuals' perceptions...
24.
Hartmann M, Otticha S, Agot K, Minnis A, Montgomery E, Roberts S
AIDS Educ Prev . 2021 Apr; 33(2):103-119. PMID: 33821679
HIV pre-exposure prophylaxis (PrEP) reduces HIV acquisition among adolescent girls and young women (AGYW). Existing evidence suggests that uptake and adherence are low among AGYW and that relationship factors such...
25.
Montgomery E, Browne E, Atujuna M, Boeri M, Mansfield C, Sindelo S, et al.
J Acquir Immune Defic Syndr . 2021 Feb; 87(3):928-936. PMID: 33633031
Background: Long-acting pre-exposure prophylaxis (LA-PrEP) formulated as implants and injections are promising prevention method strategies offering simplicity, discretion, and long dose duration. Men are important end users of LA-PrEP, and...
26.
ORourke S, Hartmann M, Myers L, Lawrence N, Gill K, Morton J, et al.
AIDS Behav . 2021 Feb; 25(7):2154-2165. PMID: 33521908
Despite high risk for HIV, South African adolescent girls and young women (AGYW) experience numerous challenges with adherence to PrEP. To better understand AGYW's motivations for PrEP and factors that...
27.
Tolley E, Zissette S, Martinez A, Palanee-Phillips T, Mathebula F, Tenza S, et al.
PLoS One . 2020 Dec; 15(12):e0242881. PMID: 33351805
In HIV prevention trials, male partners have influenced women's ability to adhere to investigational products, including antiretroviral (ARV) containing vaginal rings. Validated scales can be useful tools to systematically measure...
28.
Minnis A, Atujuna M, Browne E, Ndwayana S, Hartmann M, Sindelo S, et al.
J Int AIDS Soc . 2020 Jun; 23(6):e25528. PMID: 32544303
Introduction: Existing biomedical HIV prevention options, though highly effective, present substantial adherence challenges. End-user input on early-stage design of new HIV prevention approaches is critical to yielding products that achieve...
29.
Hartmann M, Datta S, Browne E, Appiah P, Banay R, Caetano V, et al.
J Interpers Violence . 2020 Jan; 36(23-24):NP12456-NP12480. PMID: 31959030
Hazardous drinking is an important contributing factor to intimate partner violence (IPV) occurrence. However, only a limited number of community-based alcohol reduction interventions have been tested in low- and middle-income...
30.
Hartmann M, Lanham M, Palanee-Phillips T, Mathebula F, Tolley E, Peacock D, et al.
AIDS Educ Prev . 2019 Sep; 31(5):433-451. PMID: 31550193
This article describes the development of the Community Health clinic model for Agency in Relationships and Safer Microbicide Adherence intervention (CHARISMA), an intervention designed to address the ways in which...